R

Rigello communication

260 employees

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Pharmaceutical

Date founded

1996

Funding rounds raised

Total raised

$46M

from 4 investors over 4 rounds

R

Rigello communication raised $17M on January 29, 2021

Investors: united-states-department-of-defense

R

Rigello communication raised $46M on April 30, 2003

Investors: Alta Partners, MPM Capital and Frazier Healthcare Partners

FAQ